*Correspondence: Wei Wei, [email protected] Li, [email protected] This article was submitted to Nutrition and Metabolism, a section of the journal Frontiers in Nutrition Disclaimer All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers
"I think my body just kind of got used to the drug and adjusted eventually." Doctors say patience may be key
Initially indicated for blood glucose management in Type 2 diabetes, GLP-1 receptor agonists such as Semaglutide and Tirzepatide are now being studied for their therapeutic benefits across multiple chronic inflammatory diseases
A patient with favorable FTO and GLP1R genotypes may experience more pronounced weight loss and metabolic improvements, potentially supporting greater cholesterol and triglyceride reductions
Increased EPO activity in food allergies deserves special attention
Give it 2-4 weeks after your last injection before testing, allowing the long half-life of LR3 to clear fully
